Volume 14 Issue 6
Nov.  2023
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2023  >  14(6): 831-837
Shi Xiaofeng, Dou Gufeng, Du Qing, et al. ABO-incompatible living-related kidney transplantation: report of 23 cases[J]. ORGAN TRANSPLANTATION, 2023, 14(6): 831-837. doi: 10.3969/j.issn.1674-7445.2023141
Citation: Shi Xiaofeng, Dou Gufeng, Du Qing, et al. ABO-incompatible living-related kidney transplantation: report of 23 cases[J]. ORGAN TRANSPLANTATION, 2023, 14(6): 831-837. doi: 10.3969/j.issn.1674-7445.2023141
shu

ABO-incompatible living-related kidney transplantation: report of 23 cases

doi: 10.3969/j.issn.1674-7445.2023141

  • Department of Kidney Transplantation, Tianjin First Central Hospital, Tianjin 300192, China

More Information
  • Corresponding author: Mo Chunbai, Email:mochunbaitj@126.com
  • Received Date: 2023-07-20
  • Accepted Date: 2023-09-13
    • Available Online: 2023-09-19
  • Publish Date: 2023-11-09
    Abstract
  •   Objective   To evaluate clinical efficacy and safety of ABO-incompatible (ABOi) living-related kidney transplantation.   Methods   Clinical data of 23 recipients undergoing ABOi living-related kidney transplantation were retrospectively analyzed. According to the initial blood group antibody titers in the recipients before surgery, different individualized pretreatment regimens were adopted, including oral intake of immunosuppressive drugs plus rituximab, or oral intake of immunosuppressive drugs plus plasma exchange and/or double filtration plasmapheresis plus rituximab. The blood group antibody titers before and after pretreatment, before and after kidney transplantation, and perioperative renal function and related complications were monitored. Renal allograft function and related complications were observed during postoperative follow-up.   Results   Among 23 recipients undergoing ABOi living-related kidney transplantation, except for one case presenting with hyperacute rejection during operation, the serum creatinine levels of the remaining 22 recipients were restored normal. Perioperative complications included lymphatic fistula in 4 cases, 1 case of urinary fistula, 1 case of perirenal hematoma complicated with T cell-mediated rejection, 6 cases of urinary system infection, 1 case of acute tubular necrosis, 1 case of acute pancreatitis, 1 case of blood group antibody titer rebound, and 1 case of primary disease recurrence, and all of these complications were cured after corresponding treatment. During postoperative follow-up, the graft and recipient survival rates of 22 recipients were 100%, and renal allograft function was normal. The blood group antibody titer were all ≤1:8 during follow-up. Complications during follow-up included 2 cases of severe lung infection, 1 case of antibody-mediated rejection, 2 cases of primary disease recurrence, 1 case of lymphocyst, 1 case of urinary system infection, 1 case of herpes zoster, 1 case of BK viruria and 2 cases of abnormal blood glucose levels.   Conclusions   ABOi living-related kidney transplantation may be safely performed by selecting individualized pretreatment regimens according to antibody titers by different blood groups. However, high-dose rituximab or combined use of rabbit anti-human thymocyte immunoglobulin may cause severe infectious complications in highly sensitized recipients.

     

    • FullText(HTML)
  • loading
    • References(35)
  • [1]
    ROODNAT JI, KAL-VAN GESTEL JA, ZUIDEMA W, et al. Successful expansion of the living donor pool by alternative living donation programs[J]. Am J Transplant, 2009, 9(9): 2150-2156. DOI: 10.1111/j.1600-6143.2009.02745.x.
    [2]
    KOO TY, YANG J. Current progress in ABO-incompatible kidney transplantation[J]. Kidney Res Clin Pract, 2015, 34(3): 170-179. DOI: 10.1016/j.krcp.2015.08.005.
    [3]
    AIKAWA A, SAITO K, TAKAHASHI K. Trends in ABO-incompatible kidney transplantation[J]. Exp Clin Transplant, 2015, 13(Suppl 1): 18-22.
    [4]
    TASAKI M, YOSHIDA Y, MIYAMOTO M, et al. Identification and characterization of major proteins carrying ABO blood group antigens in the human kidney[J]. Transplantation, 2009, 87(8): 1125-1133. DOI: 10.1097/TP.0b013e31819e0054.
    [5]
    TASAKI M, TATENO H, SATO T, et al. Hyporesponsiveness against donor's ABO antigens of renal grafts after ABO-incompatible kidney transplantation[J]. Clin Exp Nephrol, 2023, 27(1): 89-95. DOI: 10.1007/s10157-022-02280-3.
    [6]
    GUY P, DELAS A, ESPOSITO L, et al. Progression of histological lesions after ABO incompatible kidney transplantation[J]. Front Immunol, 2022, 13: 969998. DOI: 10.3389/fimmu.2022.969998.
    [7]
    RIVERA CF, RODRIGUEZ MC, HERMIDA TF, et al. Isoagglutinin titers in ABO-incompatible kidney transplant[J]. Transplant Proc, 2021, 53(9): 2675-2677. DOI: 10.1016/j.transproceed.2021.07.059.
    [8]
    SCURT FG, EWERT L, MERTENS PR, et al. Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis[J]. Lancet, 2019, 393(10185): 2059-2072. DOI: 10.1016/S0140-6736(18)32091-9.
    [9]
    ZSCHIEDRICH S, JÄNIGEN B, DIMOVA D, et al. One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience[J]. Nephrol Dial Transplant, 2016, 31(4): 663-671. DOI: 10.1093/ndt/gfv388.
    [10]
    OKUMI M, TOKI D, NOZAKI T, et al. ABO-incompatible living kidney transplants: evolution of outcomes and immunosuppressive management[J]. Am J Transplant, 2016, 16(3): 886-896. DOI: 10.1111/ajt.13502.
    [11]
    MARITATI F, BINI C, CUNA V, et al. Current perspectives in ABO-incompatible kidney transplant[J]. J Inflamm Res, 2022, 15: 3095-3103. DOI: 10.2147/JIR.S360460.
    [12]
    岳文龙, 刘佳, 李晓虎, 等. ABO血型不相容活体肾移植23例临床分析[J]. 临床泌尿外科杂志, 2022, 37(7): 521-526. DOI: 10.13201/j.issn.1001-1420.2022.07.007.

    YUE WL, LIU J, LI XH, et al. ABO-incompatible living donor kidney transplantation: clinical analysis of 23 cases[J]. J Clin Urol, 2022, 37(7): 521-526. DOI: 10.13201/j.issn.1001-1420.2022.07.007.
    [13]
    HEW EY, KESSARIS N, STOJANOVIC J, et al. Successful ABO and HLA incompatible kidney transplantation in children in the UK[J]. Pediatr Nephrol, 2023, 38(2): 529-535. DOI: 10.1007/s00467-022-05583-5.
    [14]
    PANDEY P, SETYA D, SINHA VK, et al. Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: single center experience of first 200 incompatible transplants[J]. J Clin Apher, 2021, 36(3): 299-312. DOI: 10.1002/jca.21860.
    [15]
    PRASAD N, CHELLAPAN A, SRIVASTAVA A, et al. ABO-incompatible repeat kidney transplantation: coping with the 'twin immunological barrier'[J]. Indian J Nephrol, 2022, 32(1): 82-86. DOI: 10.4103/ijn.IJN_64_20.
    [16]
    WATARI S, ARAKI M, WADA K, et al. ABO blood incompatibility positively affects early graft function: single-center retrospective cohort study[J]. Transplant Proc, 2021, 53(5): 1494-1500. DOI: 10.1016/j.transproceed.2021.03.043.
    [17]
    DE WEERD AE, BETJES MGH. ABO-incompatible kidney transplant outcomes: a meta-analysis[J]. Clin J Am Soc Nephrol, 2018, 13(8): 1234-1243. DOI: 10.2215/CJN.00540118.
    [18]
    SHINODA K, HYODO Y, OGUCHI H, et al. Outcome of ABO-incompatible kidney transplantation using a modified desensitization protocol without plasmapheresis[J]. Int J Urol, 2022, 29(9): 1017-1025. DOI: 10.1111/iju.14944.
    [19]
    KIM HJ, KIM JS, YANG JJ, et al. Outcome of ABO-incompatible kidney transplantation according to ABO type of transfused plasma: comparative analysis between "universal" AB and donor-type plasma[J]. Lab Med, 2022, 53(4): 369-375. DOI: 10.1093/labmed/lmab122.
    [20]
    OKADA M, NARUMI S, HASEGAWA Y, et al. Optimal dose of rituximab in ABO-incompatible kidney transplantation in patients with low anti-A/B antibody titers: a single-center retrospective cohort study[J]. Clin Transplant, 2023, 37(2): e14915. DOI: 10.1111/ctr.14915.
    [21]
    SASAKI H, HOTTA K, MITSUKE A, et al. Long-term outcome of ABO-incompatible kidney transplantation in patients treated with low-dose rituximab regimen[J]. Transplant Proc, 2021, 53(3): 989-994. DOI: 10.1016/j.transproceed.2020.10.023.
    [22]
    王毅, 罗志刚, 桂培根, 等. 供、受者ABO血型不相容保留受者脾脏的亲属活体供肾移植一例[J]. 中华器官移植杂志, 2007, 28(11): 694-695. DOI: 10.3760/cma.j.issn.0254-1785.2007.11.017.

    WANG Y, LUO ZG, GUI PG, et al. ABO incompatibility between donor and recipient: a case of living donor kidney transplantation which retained the recipient's spleen[J]. Chin J Organ Transplant, 2007, 28(11): 694-695. DOI: 10.3760/cma.j.issn.0254-1785.2007.11.017.
    [23]
    蒋鸿涛, 李涛, 任坤, 等. ABO血型不相容亲属活体肾移植的多中心研究[J]. 中华器官移植杂志, 2020, 41(5): 259-264. DOI: 10.3760/cma.j.cn421203-20200416-00120.

    JIANG HT, LI T, REN K, et al. Preliminary results of multicenter studies on ABO-incompatible kidney transplantation[J]. Chin J Organ Transplant, 2020, 41(5): 259-264. DOI: 10.3760/cma.j.cn421203-20200416-00120.
    [24]
    LANGHORST C, GANNER A, SCHNEIDER J, et al. Long-term follow-up of ABO-incompatible kidney transplantation in freiburg, germany: a single-center outcome report[J]. Transplant Proc, 2021, 53(3): 848-855. DOI: 10.1016/j.transproceed.2020.09.001.
    [25]
    LOPAU K, SYAMKEN K, RUBENWOLF P, et al. Impact of mycophenolate mofetil on wound complications and lymphoceles after kidney transplantation[J]. Kidney Blood Press Res, 2010, 33(1): 52-59. DOI: 10.1159/000289573.
    [26]
    JHA PK, BANSAL SB, RANA A, et al. ABO-incompatible kidney transplantation in india: a single-center experience of first hundred cases[J]. Indian J Nephrol, 2022, 32(1): 42-46. DOI: 10.4103/ijn.IJN_465_20.
    [27]
    SHAH Y, ALMESHARI K, BROERING D, et al. ABO-incompatible kidney transplantation: low rates of infectious complications and excellent patient survival[J]. Transplant Proc, 2019, 51(2): 512-516. DOI: 10.1016/j.transproceed.2019.01.002.
    [28]
    GARCÍA-SOBRINO R, VAZQUEZ-MARTUL D, FERNÁNDEZ-RIVERA C, et al. Postoperative events in incompatible living donor kidney transplant recipients undergoing prior desensitization[J]. Transplant Proc, 2023, 55(7): 1575-1580. DOI: 10.1016/j.transproceed.2023.04.047.
    [29]
    MOHAMED M, SWEENEY T, ALKHADER D, et al. ABO incompatibility in renal transplantation[J]. World J Transplant, 2021, 11(9): 388-399. DOI: 10.5500/wjt.v11.i9.388.
    [30]
    MANOOK M, JOHNSON R, ROBB M, et al. Changing patterns of clinical decision making: are falling numbers of antibody incompatible transplants related to the increasing success of the UK Living Kidney Sharing Scheme? a national cohort study[J]. Transpl Int, 2021, 34(1): 153-162. DOI: 10.1111/tri.13776.
    [31]
    YIN S, TAN Q, YANG Y, et al. Transplant outcomes of 100 cases of living-donor ABO-incompatible kidney transplantation[J]. Chin Med J (Engl), 2022, 135(19): 2303-2310. DOI: 10.1097/CM9.0000000000002138.
    [32]
    BORGOGNO P, FERNÁNDEZ P, DOUTHAT W, et al. ABO incompatible living donor kidney transplantation in a center in Córdoba, Argentina[J]. Medicina (B Aires), 2021, 81(6): 986-995.
    [33]
    DE WEERD AE, VAN DEN BRAND JAJG, BOUWSMA H, et al. ABO-incompatible kidney transplantation in perspective of deceased donor transplantation and induction strategies: a propensity-matched analysis[J]. Transpl Int, 2021, 34(12): 2706-2719. DOI: 10.1111/tri.14145.
    [34]
    HIRZEL C, PROJER L, ATKINSON A, et al. Infection risk in the first year after ABO-incompatible kidney transplantation: a nationwide prospective cohort study[J]. Transplantation, 2022, 106(9): 1875-1883. DOI: 10.1097/TP.0000000000004109.
    [35]
    BEGUM NAS, KASHEM TS, NOBI F, et al. Experiences of performing ABO-incompatible kidney transplantation in Bangladesh[J]. Korean J Transplant, 2022, 36(2): 111-118. DOI: 10.4285/kjt.22.0014.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (345) PDF downloads(46) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return